Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)

180.13
Delayed Data
As of Jun 21
 -3.05 / -1.67%
Today’s Change
128.58
Today|||52-Week Range
184.00
+33.78%
Year-to-Date

Today’s Trading

Previous close183.18
Today’s open183.49
Day’s range179.00 - 183.49
Volume690,733
Average volume (3 months)483,286
Market cap$10.0B
Data as of 4:00pm ET, 06/21/2018

Growth & Valuation

Earnings growth (last year)+24.18%
Earnings growth (this year)+18.53%
Earnings growth (next 5 years)+14.70%
Revenue growth (last year)+8.79%
P/E ratio24.7
Price/Sales5.10
Price/Book3.66

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...-2.57-2.44%
ALKSAlkermes Plc-7.71-15.01%
SGENSeattle Genetics Inc-0.15-0.22%
TSROTESARO Inc-0.74-1.59%
Data as of 4:00pm ET, 06/21/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)$3.24
Annual revenue (last year)$1.6B
Annual profit (last year)$487.8M
Net profit margin30.14%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Bruce C. Cozadd
President &
Chief Operating Officer
Daniel N. Swisher
Corporate headquarters
Dublin, Dublin

Forecasts